Beijing SL Pharmaceutical Co., Ltd.

XSEC:002038 Stock Report

Market Cap: CN¥7.9b

Beijing SL Pharmaceutical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Mingbo Xu

Chief executive officer

CN¥385.0k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership22.6%
Management average tenureno data
Board average tenure3.1yrs

Recent management updates

Recent updates


CEO

Mingbo Xu (60 yo)

no data

Tenure

CN¥385,000

Compensation

Dr. Mingbo Xu founded Beijing SL Pharmaceutical Co., Ltd. in December 1994 and serves as its Chairman and General Manager. He served as President at Beijing SL Pharmaceutical Co., Ltd.


Board Members

NamePositionTenureCompensationOwnership
Mingbo Xu
Founderno dataCN¥385.00k22.62%
CN¥ 1.8b
Shujie Liang
Secretary & Non-Independent Directorno dataCN¥480.00k0.19%
CN¥ 15.3m
Yulin Chen
Non Independent Directorno dataCN¥50.00kno data
Wenxin Wang
Non-Independent Director9.1yrsno datano data
Yanming Qi
Non-Employee Supervisor9.1yrsno data0.00029%
CN¥ 22.9k
Lingjia Qian
Independent Director3.1yrsCN¥50.00kno data
Longyun Cheng
Independent Director3.1yrsCN¥50.00kno data
Xuexin Zhu
Non-Employee Supervisorless than a yearno datano data

3.1yrs

Average Tenure

60yo

Average Age

Experienced Board: 002038's board of directors are considered experienced (3.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.